Experimental cancer drug 'cures almost every patient' in exciting trial - Dublin Live

The drug dostarlimab appeared to cure every patient during a clinical trial at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York

Doctors have been left astonished after an experimental cancer drug caused every patient in a trial to enter remission. The drug dostarlimab appeared to cure every patient during a clinical trial at… [+2492 chars]

full article...